Evidence map›Paper›PMID 39771100›Full record

ArticleToxics2024

Removal of the Active Pharmaceutical Substance Entecavir from Water via the Fenton Reaction or Action by the Cyanobacterium

Cléssius Ribeiro de Souza, Gabriel Souza-Silva, Carolina Paula de Souza Moreira, Olívia Maria S R Vasconcelos, Kenia Pedrosa Nunes, Cíntia Aparecida J Pereira, Marcos Paulo Gomes Mol, Micheline Rosa Silveira

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cléssius Ribeiro de SouzaFaculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.ORCID 0000-0003-0884-1202
Gabriel Souza-SilvaFaculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.ORCID 0000-0002-3740-4346
Carolina Paula de Souza MoreiraFundação Ezequiel Dias, Departamento de Pesquisa e Desenvolvimento, Belo Horizonte 30510-010, MG, Brazil.
Olívia Maria S R VasconcelosFundação Ezequiel Dias, Departamento de Pesquisa e Desenvolvimento, Belo Horizonte 30510-010, MG, Brazil.
Kenia Pedrosa NunesDepartment of Biomedical Engineering and Science, Florida Institute of Technology, Melbourne, FL 32901, USA.ORCID 0000-0002-4838-7617
Cíntia Aparecida J PereiraInstituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.
Marcos Paulo Gomes MolFundação Ezequiel Dias, Departamento de Pesquisa e Desenvolvimento, Belo Horizonte 30510-010, MG, Brazil.ORCID 0000-0002-2568-3579
Micheline Rosa SilveiraFaculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.ORCID 0000-0001-7002-4428

Funding

CNPQ NAMinas Gerais State Agency for Research and Development-FAPEMIG APQ-02426-21
6 · The paper itself

Abstract

Entecavir (ETV) is an antiviral used to treat chronic infection caused by the hepatitis B virus, which affects approximately 250 million people worldwide. In order to mitigate the impacts of ETV on the environment, including potential harm to human health, this study evaluated the use of the Fenton-like reaction, which uses iron complexed with ethylenediaminetetraacetic acid (EDTA) at neutral pH, and the microbiological action of

Indexed as

cyanobacteriadegradationentecavirFenton-like reactionMicrocystis

Identifiers

PMID39771100
PMCPMC11679440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.